Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you take fexofenadine for hay fever or urticaria and you're starting semaglutide for weight management, the question is reasonable: do these two interact? The short answer is that no clinically significant pharmacokinetic interaction between semaglutide and fexofenadine has been identified in the published evidence, but semaglutide's effect on gastric emptying means that how quickly any oral medicine is absorbed can change during treatment. Fexofenadine is a drug whose absorption is sensitive to gut transit timing, so understanding what this means in practice is worth your time. Both medicines are prescription-only treatments, and any change to your regimen should be discussed with your prescriber before you make it.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It's a scenario a fair number of people notice but don't always connect. You've been on fexofenadine for years (it keeps the itching and sneezing manageable) and a few weeks into semaglutide, something feels off. The tablets haven't changed. The dose is the same. But the effect is different.
Semaglutide works partly by slowing the rate at which the stomach empties its contents into the small intestine. For weight management, that's a feature: food lingers, fullness lasts longer, appetite falls. For oral medicines, though, delayed gastric emptying can shift the absorption curve. A tablet that normally reaches peak blood concentration within an hour or two may take longer. Whether that changes clinical effect depends on the drug in question.
Fexofenadine is absorbed via specific drug transporters in the gut wall. Its absorption is already known to be affected by fruit juices, antacids and certain other medicines — the NHS patient information for fexofenadine flags this clearly. A change in gastric transit speed is another factor that, in principle, could affect how much of the dose reaches circulation and when. The NHS semaglutide medicines page notes that because semaglutide can slow gastric emptying, patients should tell their prescriber about all oral medicines they take, particularly those where stable blood levels matter.
This doesn't mean fexofenadine becomes unsafe or useless. It means the interaction is worth a conversation, not a sudden change.
The Wegovy SmPC (the document prescribers use) includes a section on drug interactions specifically because of gastric emptying. It notes that semaglutide may affect the absorption of concomitant oral medicines and recommends monitoring for any medicines where reduced or delayed absorption would have clinical consequences. Fexofenadine isn't singled out, because the concern is a class effect rather than a specific pair.
For most antihistamines, the practical stakes are modest: if your hay fever control slips slightly, you're uncomfortable, but not in danger. That said, your prescriber reviewing your full medicines list before approving semaglutide is standard clinical practice, and it's one reason the consultation process at a GPhC-registered pharmacy exists. A real prescriber reading your answers can flag any timing sensitivities before your first pen arrives.
If you're already on semaglutide and finding fexofenadine less effective, the simplest first step is to check whether you're taking both medicines at the same time. Separating them by an hour or two may help, but ask your prescriber first, because the right adjustment depends on your individual dosing schedule. Our Wegovy treatment page covers what to expect from the medicine more broadly, including how side effects settle over the first few weeks.
One note on dose escalation: as semaglutide is titrated upward, the gastric-emptying effect is thought to be most pronounced early in treatment and may moderate over time. That means any absorption change you notice at the start of treatment may become less noticeable as your body adjusts. If you want to read about what the semaglutide 1 mg dose involves in practice, including how that early titration period is managed, that page goes into more detail.
Fexofenadine is a useful comparison case because its oral absorption is already unusually sensitive to conditions in the gut. Unlike many antihistamines, it doesn't cross the blood-brain barrier easily, which is why it causes less drowsiness, but this is partly because of the same transporter system that makes its absorption variable. P-glycoprotein and organic anion transporters are involved in how fexofenadine moves through the gut lining, and anything that disrupts this transit window can affect how much drug gets through.
The practical implication for semaglutide users is that taking fexofenadine at a consistent time each day, away from large meals and with water, remains good practice regardless of what other medicines you're taking. The BNF (the clinical reference used by UK prescribers) notes fexofenadine's known interactions with grapefruit juice and aluminium or magnesium antacids, which reduce its absorption. A slower stomach isn't in the same category of severity, but it's one more variable to be aware of.
If you're considering semaglutide for weight management and have questions about your existing medicines, there's a broader context to understand about how semaglutide works and what the clinical review process covers. Some people also have questions about whether semaglutide affects other aspects of health, and our page on semaglutide and ED addresses one area that comes up more often than you might expect. Cost context for private treatment is covered separately on our Wegovy price comparison page if that's useful at this stage. Our clinical team reviews every consultation personally before any treatment is approved.
Before starting semaglutide, list every oral medicine you take, prescription, over-the-counter, and anything you take regularly like antihistamines. Fexofenadine may not flag as a hard stop, but your prescriber needs the full picture to make a safe and informed decision. That includes the dose, how long you've been taking it, and whether you take it at a fixed time each day.
If you're already on semaglutide and feel your hay fever treatment is less effective, don't simply double the fexofenadine dose without checking first. Antihistamine doses have clinical limits, and self-adjusting without advice isn't the right move. Instead, report the change at your next prescriber review. At nume, every repeat prescription includes a clinical re-review, a prescriber looks at your progress and your medicines before anything is approved or dispatched. It's not automatic and it's not algorithmic. A real clinician reads your case. If you're at the stage where moving to a higher maintenance dose is being discussed, our page on the semaglutide 2 mg dose explains what that step typically involves.
You can reach our clinical team via the contact page if a question comes up between reviews. For questions about what other medicines interact with semaglutide, our FAQs cover a range of common scenarios, and the BNF semaglutide entry is the professional reference your GP or pharmacist will consult. The NHS semaglutide page is a clear patient-level starting point if you want to read more before your consultation.
If anything changes suddenly (new symptoms, unexpected side effects, or a feeling that something's different since you started treatment) the right call is to get proper medical advice promptly, not to wait for a scheduled review. That's not specific to this combination; it's good practice on any prescription medicine.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.